China SXT Pharmaceuticals (SXTC) Other Non-Current Liabilities (2019 - 2026)
China SXT Pharmaceuticals (SXTC) reported Other Non-Current Liabilities of $16,563 for fiscal Q4 2026 (quarter ended Mar 31, 2026), down 69.3% from $53,885 a year earlier.
Powered by 
Analysis
China SXT Pharmaceuticals (SXTC) Other Non-Current Liabilities (2019 - 2026) Analysis & Trends
Dating back to fiscal Q4 2019, China SXT Pharmaceuticals' Other Non-Current Liabilities record includes 15 quarters.
- Other Non-Current Liabilities has a five-year compound annual growth rate of -48.8% (FY2021 to FY2026).
- By fiscal year, Other Non-Current Liabilities came in at $53,885 in FY2025 (-74.8%), $213,571 in FY2024 (+90.8%), $111,951 in FY2023 (-8.8%) and $122,773 in FY2022 (-74.0%).
- Five-year quarterly Other Non-Current Liabilities spans a low of $16,191 in fiscal Q2 2026 and a high of $480,227 in fiscal Q2 2022.
- Year over year, Other Non-Current Liabilities gained in 1 of the last four quarters, with an average decline of 46.6%.
- The high point for year-over-year Other Non-Current Liabilities in five years was fiscal Q2 2022 (growth of 358.2%); the low point was fiscal Q2 2026 (a decline of 92.6%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | China SXT Pharmaceuticals | 39,500.23 | -85.91 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 16,563.00 |
| Sep 30, 2025 | 16,191.00 |
| Mar 31, 2025 | 53,885.00 |
| Sep 30, 2024 | 219,740.00 |
| Mar 31, 2024 | 213,571.00 |
| Sep 30, 2023 | 146,049.00 |
| Mar 31, 2023 | 111,951.00 |
| Sep 30, 2022 | 109,411.00 |
| Mar 31, 2022 | 122,773.00 |
| Sep 30, 2021 | 480,227.00 |
| Mar 31, 2021 | 472,282.00 |
| Sep 30, 2020 | 104,814.00 |
| Mar 31, 2020 | 113,611.00 |
| Sep 30, 2019 | 73,533.00 |
| Mar 31, 2019 | 78,317.00 |
API Access
China SXT Pharmaceuticals Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=SXTC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "SXTC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=SXTC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();